altona Diagnostics Brasil LTDA, São Paulo, the brazilian subsidiary of altona Diagnostics GmbH, obtained the approval of the registration at ANVISA, the Brazilian Health Authority, for its real-time PCR kit to detect the RNA of SARS-CoV-2, causative agent of COVID-19.

altona Diagnostics successfully achieved CE certification for the RealStar® SARS-CoV-2 RT-PCR Kit 1.0

altona Diagnostics receives Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for RealStar® SARS-CoV-2 RT-PCR Kit U.S.

RealStar® Real-Time PCR Kits – EN (for Europe) / for UK);

RealStar® Real-Time PCR Kits – EN (for UK);

RealStar® Real-Time PCR Kit – FR;

RealStar® Real-Time PCR Kit – IT;

RealStar® Real-Time PCR Kit RUO – EN;

RealStar® Real-Time PCR Kit RUO – for Latin America (ES;PT)

First evaluation for our RealStar® SARS-CoV-2 RT-PCR Kit published by LGL Bavarian Health and Food Safety Authority

Information on our events and which trade fairs you’ll be able to find us ! Postponements possible!